Piper Sandler analyst Stephen Scouten downgrades First Bancorp (NASDAQ:FBNC) from Overweight to Neutral and raises the price target from $49 to $52.
Halozyme, Chugai Ink $185M ENHANZE Technology Licensing Pact
Halozyme Therapeutics Inc (NASDAQ: HALO) has